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Background
The increasing demand for biopharmaceuticals produced
in mammalian cells has lead industries to enhance biopro-
cess volumetric productivity through different strategies.
Among them, media development is of major interest [1].
According to the increasing constraints regarding the use
of animal derived components on industrial bioprocesses
but also the drawbacks of its depletion from cell culture
[2], the main goal of the present work was to provide dif-
ferent cell culture platforms which are suitable for a wide
range of applications depending on the type and the final
use of the product obtained.
Materials and methods
The cell line HEK293SF-3F6 employed in this study was
kindly provided by Dr. A.Kamen, NRC-BRI. The basal
media tested were CDM4HEK293, SFM4HEK293 and
SFMTransFx-293 (Hyclone, Thermo Scientific) supple-
mented -when indicated- with FBS (Invitrogen) and/or
Cell Boost 5 (80 g/L) (Hyclone, Thermo Scientific).
Viable cell density and viability were determined by try-
pan blue exclusion method and manual counting using
an haemocytometer. The adenovirus strain HAdV-5
(ΔE1/E3) encoding pCMV-GFP was used for infection
experiments. All infections were carried out at MOI≈1
TOI≈0.5 × 106cell/mL in 6-well-plate. Harvesting was
performed 48 hpi.
Viral titration was performed by Flow cytometry on a
FACS Canto (Becton and Dickinson, Bioscience) by
adaption of a protocol previously described [3].
Results
The first part of this work was focused on screening differ-
ent serum-free cell culture media specifically recommended
for HEK293 cell line. As shown in Figure 1A top panel, cul-
tures performed in HyQ SFM4HEK293 and HyQ
SFMTransFx-293 showed better cell growth than HyQ
CDM4HEK293, reaching maximum cell densities of about
3.5 × 106 cell/mL, 2 × 106 cell/mL and less than 1 × 106
cell/mL respectively. In order to evaluate whether the sub-
stitution of critical serum components have satisfactorily
been performed in the media tested without affecting cell
growth, the addition of fetal bovine serum (FBS) was
assessed. FBS depletion was acceptable only in HyQ
SFM4HEK293 as the other cell media reached higher
cell densities when FBS was added (up to 7-fold increment
of Xvmax). Regarding the screening of Animal derived com-
ponent free supplements, three chemically defined supple-
ments were tested but only one (Cell Boost 5, onwards
CB5) significantly enhanced cell growth. This supplement
enabled to reach higher cell densities in all media tested:
2-fold up in HyQ SFM4HEK293 and CDM4HEK293 and
5-fold increment in HyQ SFMTransFx-293 (Figure 1A, bot-
tom panel).
The results obtained so far showed that supplementation
of all cell media tested is recommended in order to
achieve higher cell density cultures. Among all the condi-
tions, HyQSFMTransFx-293 was the media which sup-
ported the highest Xvmax with both supplements (FBS and
CB5). Therefore, this medium was selected for tuning the
final concentration of each supplement. Among the stu-
died concentration range for FBS (2.5-10% v/v) and for
CB5 (2.5-20%) it was determined that the best conditions
were 5% for FBS and 10% for CB5 solution. At these con-
centrations, Xvmax achieved were (7.14 ± 0.56*10
6 cell/mL)
and (12.63 ± 1.76*106 cell/mL) respectively (Figure 1B).
Interestingly, CB5 enabled to extend μmax phase while FBS
increased μmax value, as previously detected in the initial
media screening (Table 1). The combination of supple-
ments (5% FBS and 10%CB5) resulted in an Xvmax as high
as 16.77 ± 0.70 × 106cell/mL in batch culture, with an
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increment in specific growth rate of 15% in comparison to
those cultures in which FBS was deprived. Specific growth
rate was maintained for 144 h of cell culture.
From the range of applications in which HEK293 can
be used, the work carried out in this work was directed
to recombinant adenovirus production. Hence, the eva-
luation of the effect of supplementation in the cell
media selected on adenovirus infection efficiency and
final titer obtained was evaluated (Figure 1C). Efficiency
of infection was around 63% as expected for an effective
infection [4] in all conditions. In regards to adenovirus
production, FBS increased it up to fivefold, whereas CB5
supplementation did not affect significantly, and the
addition of both supplements almost doubled the viral
production in comparison to basal medium. It is pro-
posed that an increment of osmolarity due to the addi-
tion of both supplements might explain the slight
reduction on productivity in comparison to the addition
of FBS solely [5].
Conclusions
Two culture platforms are proposed for two possible
scenarios in basis of the Xvmax reached: (1) HyQSFM-
TransFx-293 CB5 supplemented -10% v/v- for animal
derived component Free required bioprocesses (Xvmax=
12.6 × 106 cell/mL) and (2) HyQSFMTransFx-293 FBS
Figure 1 (A) Comparison of cell growth profiles of HEK293 cell cultures in serum-free cell media (top panel) and in the same cell media FBS
supplemented (middle panel) or CB5 supplemented (bottom panel). (B) HyQ SFMTransFx-293 cell cultures with the best concentrations
encountered for FBS and CB5 and combination of supplements. (C) Evaluation of the effect of supplement addition on efficiency of infection
and Viral Titer obtained.
Table 1 Kinetic parameters for HEK293 cell cultures corresponding to the profiles depicted in Figure 1.
HyQ CDM4HEK293 HyQ SFM4HEK293 HyQ
SFMTransFx-293
No adition Xvmax (×10
6 cell·mL-1) 0.85 ± 0.0 3.53 ± 0.21 2.1 ± 0.12
μmax (×10
-2 h-1) 1.06 ± 0.01 2.46 ± 0.14 2.43 ± 0.03
tμ (h) 96 74 74
5% FBS Xvmax (×10
6 cell·mL-1) 6 ± 0.0 4.67 ± 0.48 7.02 ± 0.06
μmax (h
-1) 2.61 ± 0.04 2.8 ± 0.05 2.67 ± 0.01
tμ (h) 95 71 72
5%CB5 Xvmax (×10
6 cell·mL-1) 4.11 ± 0.33 7.29 ± 0.18 9.75 ± 0.25
μmax (h
-1) 2.1 ± 0.06 2.06 ± 0.03 2.17 ± 0.03
tμ (h) 92 69 116
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and CB5 supplemented -5% and 10% v/v respectively-
for animal derived component containing bioprocesses
(Xvmax= 16.7 × 10
6 cell/mL). In both cases, μmax and tμ
values were preserved or even improved with respect to
basal media and any of the supplements negatively
affected the adenovirus production when compared to
non-supplemented infections.
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